利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

27 条记录 (耗时 0.043 秒)

    Soft-switching half-bridge inverter power supply system
    22.
    发明授权
    Soft-switching half-bridge inverter power supply system 有权
    软开关半桥逆变电源系统

    公开(公告)号：US07042740B2

    公开(公告)日：2006-05-09

    申请号：US11063822

    申请日：2005-02-23

    申请人： Keiki Morimoto ,  Toshimitsu Doi ,  Kazuhiro Tanaka ,  Hirokazu Ioroi ,  Haruhiko Manabe

    发明人： Keiki Morimoto ,  Toshimitsu Doi ,  Kazuhiro Tanaka ,  Hirokazu Ioroi ,  Haruhiko Manabe

    IPC分类号： H02M3/335 ,  H02M7/538

    CPC分类号： H02M1/34 ,  B23K9/1043 ,  H02M3/3376 ,  H02M7/487 ,  H02M2001/342 ,  Y02B70/1491

    摘要： An inverter power supply system includes a half-bridge inverter circuit which includes a first switching element, a second switching element, a first auxiliary capacitor and a second auxiliary capacitor for converting a DC voltage from a DC power supply circuit to an AC voltage. An output control circuit outputs a first output control signal and a second output control signal with a phase difference of a half cycle to control the inverter circuit. An inverter driving circuit turns on the first (or second) switching element when the first (or second) output control signal turns ON while turning off the first (or second) switching element upon lapse of a first (or second) delay time for allowing the first (or second) auxiliary capacitor to discharge to a predetermined level after the first (or second) output control signal turns OFF.

    摘要翻译： 逆变器电源系统包括半桥逆变器电路，其包括第一开关元件，第二开关元件，第一辅助电容器和用于将来自直流电源电路的直流电压转换为交流电压的第二辅助电容器。 输出控制电路输出具有半周期的相位差的第一输出控制信号和第二输出控制信号，以控制逆变器电路。 当第一（或第二）输出控制信号接通时，逆变器驱动电路接通第一（或第二）开关元件，同时在第一（或第二）延迟时间经过第 第一（或第二）辅助电容器在第一（或第二）输出控制信号关闭之后放电到预定电平。

    Derivatives of benzofuran or benzodioxazole compounds
    23.
    发明授权
    Derivatives of benzofuran or benzodioxazole compounds 失效
    苯并呋喃或苯并恶唑化合物的衍生物

    公开(公告)号：US06716987B1

    公开(公告)日：2004-04-06

    申请号：US10023091

    申请日：2001-12-20

    申请人： Etsuo Ohshima ,  Takashi Kawakita ,  Koji Yanagawa ,  Kyoichiro Iida ,  Rie Koike ,  Yoshisuke Nakasato ,  Tohru Matsuzaki ,  Kenji Ohmori ,  Soichiro Sato ,  Hidee Ishii ,  Haruhiko Manabe ,  Michio Ichimura ,  Fumio Suzuki

    发明人： Etsuo Ohshima ,  Takashi Kawakita ,  Koji Yanagawa ,  Kyoichiro Iida ,  Rie Koike ,  Yoshisuke Nakasato ,  Tohru Matsuzaki ,  Kenji Ohmori ,  Soichiro Sato ,  Hidee Ishii ,  Haruhiko Manabe ,  Michio Ichimura ,  Fumio Suzuki

    IPC分类号： C07D41300

    CPC分类号： C07D307/79 ,  C07D307/94 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14

    摘要： An oxygen-containing heterocyclic compound represented by following Formula (I): wherein R1 and R2 independently represent hydrogen, lower alkyl, cyano, —(CH2)n—E1—CO—G1 (wherein E1 represents a bond, O, or NH; and G1 represents hydrogen, substituted or unsubstituted lower alkyl, OR6, or NR7R8; and n represents an integer of 0 to 4), or the like; R1 and R2 are combined to represent a saturated carbon ring together with a carbon atom adjacent thereto; or R2, and R11 or R13 described below are combined to form a single bond; R3 represents hydrogen, phenyl, or halogen; R4 represents hydroxy, lower alkoxy, or the like; A represents —C(R9)(R10)— or O; B represents O, NR11, —C(R12)(R13)—, or —C(R14)(R15)— C(R16)(R17)—; D represents (i) —C(R18)(R19)—X— (wherein X represents —C(R21)(R22)—, S, or NR23), (ii) —C(R19a)═Y— [Y represents —C(R24)—Z— (wherein Z represents CONH, CONHCH2, or a bond), or N], or (iii) a bond; and R5 represents aryl, an aromatic heterocyclic group, cycloalkyl, pyridine-N-oxide, cyano, or lower alkoxycarbonyl; or pharmaceutically acceptable salts thereof.

    摘要翻译： 由下式（I）表示的含氧杂环化合物：其中R 1和R 2独立地表示氢，低级烷基，氰基， - （CH 2）nE 1 -CO-G 1（其中 E 1表示键，O或NH;且G 1表示氢，取代或未取代的低级烷基，OR 6或NR 7 R 8; n表示0〜 4）等; R 1和R 2相互结合形成饱和碳环和与其相邻的碳原子。 或R 2，以及下述R 11或R 13组合形成单键; R 3表示氢，苯基或卤素; R 4表示羟基，低级烷氧基等; A表示-C（R 9）（R 10） - 或O; B表示O，NR 11，-C（R 12）（R 13） - 或-C（R 14）（R 15）-C（R 16）（R 16） <17>） - ; D表示（i）-C（R 18）（R 19）-X-（其中X表示-C（R 21）（R 22） - ，S或NR 23） ，（ii）-C（R 19）= Y- [Y表示-C（R 24） - Z-（其中Z表示CONH，CONHCH 2或键）或N]或（iii） 一个债券 R 5表示芳基，芳香族杂环基，环烷基，吡啶-N-氧化物，氰基或低级烷氧基羰基; 或其药学上可接受的盐。

    Oxygen-containing heterocyclic compounds
    24.
    发明授权
    Oxygen-containing heterocyclic compounds 失效
    含氧杂环化合物

    公开(公告)号：US06376535B2

    公开(公告)日：2002-04-23

    申请号：US09795093

    申请日：2001-03-01

    申请人： Etsuo Ohshima ,  Koji Yanagawa ,  Haruhiko Manabe ,  Ichiro Miki ,  Yoshiaki Masuda

    发明人： Etsuo Ohshima ,  Koji Yanagawa ,  Haruhiko Manabe ,  Ichiro Miki ,  Yoshiaki Masuda

    IPC分类号： A61K31335

    CPC分类号： C07D405/04 ,  C07D317/46 ,  C07D319/20 ,  C07D407/04 ,  C07D407/08

    摘要： The present invention relates to oxygen-containing heterocyclic compounds represented by the following formula (I): wherein m represents an integer of 0 to 4; R1, R2, R3 and R4 independently represent a hydrogen atom, substituted or unsubstituted lower alkyl, etc.; R5 represents substituted or unsubstituted lower alkoxy etc.; R6 represents a hydrogen atom etc.; and Y represents the following formula (II): wherein R9 represents cyano etc., R10 represents a hydrogen atom etc., R11 represents carboxy etc., and R12 represents a hydrogen atom etc.; and the like; or pharmaceutically acceptable salts thereof.

    摘要翻译： 本发明涉及由下式（I）表示的含氧杂环化合物：其中m表示0至4的整数; R 1，R 2，R 3和R 4独立地表示氢原子，取代或未取代的低级烷基等; R5表示取代或未取代的低级烷氧基等。 R6表示氢原子等。 Y表示下式（II）：其中，R9表示氰基等，R10表示氢原子等，R11表示羧基等，R12表示氢原子等。 等等; 其药学上可接受的盐。

    Imidazoquinolone derivatives
    27.
    发明授权
    Imidazoquinolone derivatives 失效
    咪唑喹啉酮衍生物

    公开(公告)号：US4994468A

    公开(公告)日：1991-02-19

    申请号：US489025

    申请日：1990-03-05

    申请人： Fumio Suzuki ,  Takeshi Kuroda ,  Yoshisuke Nakazato ,  Kenji Ohmori ,  Haruhiko Manabe

    发明人： Fumio Suzuki ,  Takeshi Kuroda ,  Yoshisuke Nakazato ,  Kenji Ohmori ,  Haruhiko Manabe

    IPC分类号： C07D471/04

    CPC分类号： C07D471/04

    摘要： Novel imidazoquinolone derivative represented by the formula (I); ##STR1## wherein R.sup.1 represents hydrogen, alkyl, cycloalkyl, alkenyl aralkyl, aralkenyl or substituted or unsubstituted aryl; X represents nitrogen or ##STR2## where R.sup.2 is hydrogen, hydroxyl, alkyl, cycloalkyl, alkenyl, aralkyl, aralkenyl, substituted or unsubstituted aryl, thiol, halogen, substituted or unsubstituted aromatic heterocyclic group, or --(CH.sub.2).sub.m CO.sub.2 R.sup.6 where R.sup.6 is hydrogen or lower alkyl and m is an integer of 0 to 3; Y represents oxygen or sulfur; R.sup.3 represents alkyl, cycloalkyl, alkoxyalkly, alkenyl, aralkyl, aralkenyl, --(CH.sub.2).sub.n -- Het where Het is substituted or unsubstituted aromatic heterocyclic group and n is an integer of 1 to 3 or --(CH.sub.2).sub.n CO.sub.2 R.sup.6a where n has the same meaning as defined above and R.sup.6a has the same meaning as defined as to R.sup.6 ; each of R.sup.4 and R.sup.5 independently represents hydrogen, lower alkyl, trifluoromethyl, cycloalkyl, halogen, hydroxyl, lower alkoxyl, lower alkylthio, nitro, amino, lower alkylamino, lower alkanoylamino, aroylamino, lower alkanoyl or aroyl; and a pharmaceutically acceptable salt thereof. The Compound (I) and a pharmaceutically acceptable salt thereof show bronchodilatory and antiallergic activities, and are useful for treating respiratory disorders such as bronchial asthma.